الفهرس | Only 14 pages are availabe for public view |
Abstract HCC is a major health problem in Egypt. Liver transplantation is a lifesaving and effective treatment of end-stage liver failure. However transplant recipients can suffer from serious side effects of long-term immunosuppression and they can lose their allografts because of rejection. Our aim is to evaluate the value of serum miR-122 , miR-194 and miR-148a as biomarkers for diagnosis of rejection after liver transplantation. Subject and Methods: Blood samples were taken from 30 patients who prepared to liver transplantation process. Also 50 blood samples from controls were taken. The following were done: history taking, general examination, complete blood picture, liver function tests, hepatitis markers by ELIZA. Serum was separated for detection of: miR-122, miR-194 and miR-148a by real |